.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
QuintilesIMS
Healthtrust
UBS
AstraZeneca
Julphar
Queensland Health
US Army
Cerilliant
Boehringer Ingelheim

Generated: July 25, 2017

DrugPatentWatch Database Preview

DARVON Drug Profile

« Back to Dashboard

Which patents cover Darvon, and when can generic versions of Darvon launch?

Darvon is a drug marketed by Xanodyne Pharm and Aaipharma Llc and is included in six NDAs.

The generic ingredient in DARVON is aspirin; propoxyphene napsylate. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; propoxyphene napsylate profile page.

Summary for Tradename: DARVON

Patents:0
Applicants:2
NDAs:6
Bulk Api Vendors: see list18
Patent Applications: see list4,872
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DARVON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xanodyne Pharm
DARVON
propoxyphene hydrochloride
CAPSULE;ORAL010997-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Xanodyne Pharm
DARVON-N
propoxyphene napsylate
TABLET;ORAL016862-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Xanodyne Pharm
DARVON COMPOUND-65
aspirin; caffeine; propoxyphene hydrochloride
CAPSULE;ORAL010996-007Mar 8, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Aaipharma Llc
DARVON-N W/ ASA
aspirin; propoxyphene napsylate
CAPSULE;ORAL016829-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Xanodyne Pharm
DARVON
propoxyphene hydrochloride
CAPSULE;ORAL010997-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Moodys
Chinese Patent Office
Deloitte
Julphar
Covington
AstraZeneca
Federal Trade Commission
Queensland Health
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot